YOLFTbeta
30

Fuan Pharmaceutical Group Co

300194 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

3.53CNY-0.07 (-1.94%)

Price History

Full chart

Market Stats

Previous Close3.60
Open3.62
Day Range3.51 – 3.62
52-Week Range3.24 – 4.93
Volume11.09M
Market Cap4.63B
P/E (TTM)97.25
Forward P/E294.12
EPS0.04
Dividend Yield1.80%
Beta0.24
50-Day Avg3.87
200-Day Avg4.06

About

Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, research and develops, produces, and sells chemical drugs in the People's Republic of China and internationally. It offers APIs; intermediates; and FDFs, such as anti-tumor, specialty drugs, antibiotics, as well as freeze-drying preparation for injection. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd. and changed its name to Fuan Pharmaceutical (Group) Co., Ltd. in August 2013. The company was founded in 2004 and is headquartered in Chongqing, the People's Republic of China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Lu Wang
  • Employees2.99K
  • HeadquartersNo. 2, Huangyang Road, Chongqing, China, 401121, China
  • Websitehttps://www.fapharm.com

Leadership

  • Mr. Lu WangGM & Executive Director · b. 1984
  • Mr. Tao HuangVice Chairman, Deputy GM & Director · b. 1971
  • Mr. Xue Song YuDeputy GM, CFO & Director · b. 1969
  • Mr. Qin TangSecretary of the Board of Directors & Director · b. 1969
  • Ms. Jing FengDeputy General Manager · b. 1974
  • Mr. Wei WangDeputy General Manager · b. 1967
  • Xiao Li GanAccounting Supervisor

Financials

Income Statement

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue93.44M198.46M324.53M464.01M358.55M420.02M357.78M448.57M708.10M1.30B2.09B2.67B2.78B2.37B2.45B2.42B2.65B2.39B1.74B
Growth (%)-+112.39%+63.53%+42.98%-22.73%+17.14%-14.82%+25.38%+57.86%+83.17%+61.20%+27.67%+4.18%-14.83%+3.58%-1.28%+9.33%-9.68%-27.31%
Cost of Revenue72.70M112.93M167.24M248.38M215.26M269.41M245.57M311.60M402.89M706.63M934.52M1.06B1.03B839.22M935.97M1.07B1.28B1.17B1.10B
Gross Profit20.74M85.53M157.29M215.63M143.29M150.60M112.21M136.97M305.21M590.38M1.16B1.61B1.75B1.53B1.52B1.36B1.37B1.22B642.58M
Gross Margin22.20%43.10%48.47%46.47%39.96%35.86%31.36%30.53%43.10%45.52%55.30%60.35%62.93%64.56%61.85%55.97%51.63%50.91%36.97%
Operating Expense14.79M31.30M51.86M70.16M31.99M52.32M68.93M83.16M227.25M334.62M827.11M1.93B1.42B1.29B2.11B1.18B1.07B896.68M546.20M
Operating Income5.95M54.22M105.42M145.47M111.30M98.28M43.28M53.80M77.96M255.76M329.17M-321.14M326.59M240.77M-591.00M178.53M298.49M320.85M96.38M
Operating Margin6.37%27.32%32.49%31.35%31.04%23.40%12.10%11.99%11.01%19.72%15.74%-12.03%11.74%10.17%-24.09%7.37%11.27%13.42%5.54%
EBITDA12.74M63.02M122.26M159.59M130.48M134.19M79.44M100.58M168.67M389.21M482.40M-180.33M473.81M407.63M-395.87M400.76M529.12M533.12M310.67M
EBITDA Margin13.63%31.75%37.67%34.39%36.39%31.95%22.20%22.42%23.82%30.01%23.07%-6.76%17.04%17.21%-16.14%16.55%19.98%22.29%17.87%
Net Income5.36M45.70M90.67M123.14M95.23M88.51M38.37M45.71M64.90M221.96M284.81M-359.98M292.83M209.37M-296.91M204.61M231.87M279.84M77.00M
Net Income Margin5.74%23.03%27.94%26.54%26.56%21.07%10.72%10.19%9.17%17.11%13.62%-13.49%10.53%8.84%-12.10%8.45%8.76%11.70%4.43%
R&D1.28M1.85M6.20M8.13M4.89M10.48M15.98M13.82M21.89M52.41M96.64M119.76M108.02M86.94M120.38M142.89M135.03M156.85M134.66M
R&D as % of Total Revenue1.37%0.93%1.91%1.75%1.36%2.50%4.47%3.08%3.09%4.04%4.62%4.49%3.88%3.67%4.91%5.90%5.10%6.56%7.75%
Interest Expense3.38M2.86M3.44M1.67M499.88K433.13K923.33K415.33K7.15M12.89M1.19M1.55M3.07M10.73M21.82M27.54M30.39M23.85M22.15M
Interest Expense % of Total Revenue3.62%1.44%1.06%0.36%0.14%0.10%0.26%0.09%1.01%0.99%0.06%0.06%0.11%0.45%0.89%1.14%1.15%1.00%1.27%

Balance Sheet

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets80.89M202.59M273.62M346.14M1.82B1.80B1.86B1.83B2.48B4.40B4.69B4.29B4.74B5.97B5.71B5.88B5.98B5.98B5.76B
Total Liabilities72.58M91.83M110.31M65.09M124.69M84.20M138.47M124.69M342.91M434.00M518.24M598.62M746.59M1.42B1.84B1.93B1.83B1.58B1.40B
Total Equity4.51M95.89M156.28M275.07M1.66B1.70B1.70B1.71B2.13B3.96B4.17B3.69B3.99B4.10B3.73B3.95B4.14B4.40B4.36B
Cash6.22M16.78M32.28M39.70M1.18B1.02B804.31M761.45M241.02M276.75M352.62M600.74M664.32M853.39M981.13M688.53M991.84M846.31M886.62M
Total Debt9.40M9.40M39.20M18.20M3.80M299.97K165.34K-135.40M54.00M-87.00M115.69M601.71M906.03M714.20M837.81M527.35M-
Net Debt3.18M-7.38M6.92M-21.50M-1.17B-1.02B-804.14M-761.45M-105.62M-222.75M-352.62M-513.74M-548.63M-251.68M-75.10M25.66M-98.98M-318.96M-

Cash Flow

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow18.92M49.23M62.75M105.74M64.85M62.77M89.61M-31.27M161.03M374.16M453.37M267.68M295.63M162.55M257.13M339.50M328.98M303.59M312.32M
Investing Cash Flow-17.11M-42.32M-34.05M-72.91M-206.37M-149.49M-262.29M23.70M-581.32M-890.87M-236.42M12.67M-274.96M-316.84M-349.24M-440.01M-93.62M-264.83M-
Financing Cash Flow1.61M3.80M-13.21M-25.42M1.28B-71.05M-40.90M-35.29M-100.23M546.61M-134.84M-39.03M31.11M326.98M211.41M-171.68M46.25M-227.93M-
Capital Expenditure14.58M34.48M31.04M68.74M100.92M132.44M171.97M55.30M92.16M153.91M84.62M132.16M223.80M344.53M413.03M383.10M215.68M241.79M108.43M
Free Cash Flow4.33M14.75M31.71M37.01M-36.07M-69.67M-82.36M-86.57M68.87M220.25M368.75M135.52M71.83M-181.98M-155.91M-43.60M113.30M61.80M203.89M
Dividends Paid887.07K837.24K22.68M6.67M499.89K40.30M40.94M35.10M32.93M40.95M80.60M120.39M2.37M59.49M59.49M28.09M93.98M84.22M104.99M
FCF to OCF22.91%29.96%50.53%35.00%-55.62%-111.00%-91.91%276.86%42.77%58.86%81.33%50.63%24.30%-111.95%-60.63%-12.84%34.44%20.36%65.28%
Dividend Paid to FCF20.47%5.68%71.52%18.02%-1.39%-57.84%-49.71%-40.54%47.81%18.59%21.86%88.84%3.30%-32.69%-38.15%-64.42%82.95%136.28%51.49%

Earnings

Report DateMar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Aug 19, 2014Oct 23, 2014Mar 28, 2015Apr 24, 2015Aug 25, 2015Oct 23, 2015Feb 26, 2016Apr 25, 2016Aug 27, 2016Oct 28, 2016Feb 28, 2017Apr 25, 2017Aug 28, 2017Oct 27, 2017Mar 30, 2018Apr 26, 2018Aug 24, 2018Oct 26, 2018Mar 28, 2019Mar 31, 2019Jun 30, 2019Sep 30, 2019Mar 28, 2020Apr 25, 2020Aug 28, 2020Oct 30, 2020Mar 31, 2021Apr 29, 2021Aug 27, 2021Oct 29, 2021Dec 31, 2021Apr 26, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023May 24, 2024Jun 30, 2024Oct 24, 2024Dec 31, 2024Apr 23, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------0.060.070.11-0.04-----0.04--0.04-----------------------------------
EPS Actual0.050.040.020.010.030.040.030.010.020.010.010.010.020.040.020.030.010.020.030.020.040.050.060.020.080.080.020.040.070.070.05-0.490.060.070.060.060.060.050.050.010.050.040.06-0.400.030.040.040.060.070.060.08-0.020.100.080.07-0.020.060.040.04-0.070.050.03
Surprise--------------33.33%-71.43%-72.73%--50.00%------50.00%---50.00%-----------------------------------
Timing-------------Pre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-market------------Pre-market-------After-hours-Pre-market-Pre-market-----

Key Statistics & Ratios

Market Cap4.63B
Enterprise Value4.34B
Trailing P/E97.25
Forward P/E294.12
PEG Ratio0.00
Price / Sales2.79
Price / Book1.05
EPS0.04
Book Value3.70
Revenue (TTM)1.66B
Gross Profit (TTM)603.21M
EBITDA287.11M
Profit Margin3.60%
Operating Margin11.89%
Return on Equity1.34%
Return on Assets0.93%
Shares Outstanding1.19B
Shares Float839.82M
Beta0.24
Dividend Yield1.80%
Dividend Rate0.07
Payout Ratio99.60%

Dividends

20261×
0.05May 28, 2026
20252×
0.02Sep 25, 20250.05May 28, 2025
20241×
0.05Jun 4, 2024
20231×
0.05May 12, 2023
20211×
0.05May 14, 2021
20201×
0.05May 15, 2020
20181×
0.10May 8, 2018
20171×
0.07May 10, 2017
20161×
0.03May 25, 2016
20151×
0.03Apr 29, 2015
20141×
0.04May 13, 2014
20131×
0.05May 14, 2013
20121×
0.05May 18, 2012

Stock Splits

  • May 10, 201730:10
  • May 13, 201415:10
  • May 14, 201313:10